These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. CD3- CD56+ non-Hodgkin's lymphomas with an aggressive behavior related to multidrug resistance. Drénou B; Lamy T; Amiot L; Fardel O; Caulet-Maugendre S; Sasportes M; Diebold J; Le Prisé PY; Fauchet R Blood; 1997 Apr; 89(8):2966-74. PubMed ID: 9108417 [TBL] [Abstract][Full Text] [Related]
8. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement. Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360 [TBL] [Abstract][Full Text] [Related]
9. TCR-CD56+CD2+ nasal lymphomas with membrane-localized CD3 positivity: are the CD3+ cells neoplastic or reactive? Tao Q; Chiang AK; Srivastava G; Ho FC Blood; 1995 May; 85(10):2993-6. PubMed ID: 7537987 [No Abstract] [Full Text] [Related]
10. A cutaneous agranular CD2- CD4+ CD56+ "lymphoma": report of two cases and review of the literature. Kameoka J; Ichinohasama R; Tanaka M; Miura I; Tomiya Y; Takahashi S; Yamada M; Ishikawa I; Kadowaki I; Sasaki O; Kimura J; Meguro K; Ooya K; Ito S Am J Clin Pathol; 1998 Oct; 110(4):478-88. PubMed ID: 9763034 [TBL] [Abstract][Full Text] [Related]
11. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136 [TBL] [Abstract][Full Text] [Related]
12. Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma. Di Noto R; Pane F; Camera A; Luciano L; Barone M; Lo Pardo C; Boccuni P; Intrieri M; Izzo B; Villa MR; Macrí M; Rotoli B; Sacchetti L; Salvatore F; Del Vecchio L Leukemia; 2001 Oct; 15(10):1641-9. PubMed ID: 11587224 [TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic Dissection of Normal Peripheral Blood NK Associated (NKa) Subpopulations by Flow Cytometry: Morphological Features and Relationships Between Membrane NKa (CD11b, CD 16, CD56 and CD57) arid T-cell (CD2, CD3, TCR, CD5, CD7, CD8 and CD38) Associated Determinant Expression. Richards SJ; Scott CS Leuk Lymphoma; 1990; 2(1-2):111-26. PubMed ID: 27456578 [TBL] [Abstract][Full Text] [Related]
18. CD56-positive (nasal-type T/NK cell) lymphoma arising on the skin. Report of two cases and review of the literature. Ansai S; Maeda K; Yamakawa M; Matsuda M; Saitoh S; Suwa S; Saitoh H; Ohtsuka M; Iwatsuki K J Cutan Pathol; 1997 Sep; 24(8):468-76. PubMed ID: 9331892 [TBL] [Abstract][Full Text] [Related]
19. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma. Nichols GE; Normansell DE; Williams ME Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849 [TBL] [Abstract][Full Text] [Related]
20. CD2-, CD4+, CD56+ agranular natural killer cell lymphoma of the skin. Uchiyama N; Ito K; Kawai K; Sakamoto F; Takaki M; Ito M Am J Dermatopathol; 1998 Oct; 20(5):513-7. PubMed ID: 9790118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]